Skip to main content
Clinical Trials/NCT05599386
NCT05599386
Active, Not Recruiting
N/A

Predictors of Acute and Persistent Postoperative Pain in Lung Cancer Surgery

Jannie Bisgaard Stæhr1 site in 1 country100 target enrollmentNovember 1, 2022
ConditionsLung Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Jannie Bisgaard Stæhr
Enrollment
100
Locations
1
Primary Endpoint
Numerical Rating Scale
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The aim of this observational study is to investigate if preoperative quantitative sensory testing, anxiety and depression symptoms, and biological markers are associated with the risk of developing acute and chronic postoperative pain after video-assisted Thoracoscopic surgery (VATS).

Detailed Description

This observational study examine acute and chronic postoperative pain in patients undergoing VATS. In the study preoperative biomarkers, quantitative sensory testing and questionnaires are used to create prediction models for acute and chronic postoperative pain. The study will serve as background information on the risk factors and predictive factors as well as an exploration of the impact of surgical stress from VATS on circulation microRNA and inflammatory mediators.

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
August 6, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Jannie Bisgaard Stæhr
Responsible Party
Sponsor Investigator
Principal Investigator

Jannie Bisgaard Stæhr

Chief Physician

Aalborg University Hospital

Eligibility Criteria

Inclusion Criteria

  • Adults independent of sex with an age of ≥ 18 years
  • Patients scheduled for VATS as a part of either examination or radical treatment of lung cancer

Exclusion Criteria

  • Patients who are unable to understand oral and written information.
  • Patients with known chronic pain in the thorax which have been persisting for at least six months before the day of surgery.
  • Pregnant and nursing women.
  • Patients receiving a planned preoperative epidural blockade during their stay.
  • Patients converted to open surgery.

Outcomes

Primary Outcomes

Numerical Rating Scale

Time Frame: 365 days postoperative

Pain intensity on a Numerical Rating Scale ranging from 0 indicating no pain to 10 indicating worst pain imaginable at follow up. Collected using the Brief Pain Index

Secondary Outcomes

  • Total equipotent opioid dose(Total equipotent opioid dose in milligrams during the first 48 hours after surgery.)
  • Time to first administration of opioid(Time in hours to first postoperative administration of Pro Re Nata (PRN) opioids)
  • Mobilisation(48 hours postoperative)
  • Patient-reported satisfaction of postoperative pain management assessed by self-made questionnaire in Danish(Measured twice. Once 48 hours after surgery or at non fixed time(on average 4 days and a maximum of 3 months) as well as at 365 days)

Study Sites (1)

Loading locations...

Similar Trials